4
Changes in Ownership
Kura Oncology, Inc. Filed Acc 0001209191-19-005130
Options or other derivatives
- Head of Development & CMO acquired 140,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
GUALBERTO ANTONIO · Head of Development & CMO
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-01-22 | Grant or award : show line 1 in the form Option to purchase common stock | +140,000 | $15.47 | 2029-01-21 | 140,000 | 140,000 | D |
Loading xslF345X03/doc4.xml…